A great night was had by all at the 2021 Women in Technology Awards
The Mater Research-led Queensland Family Cohort study wants 2500 Aboriginal and Torres Strait Islander families that are currently pregnant to join the project and help improve health for future...
New Mater Research has discovered the main biological roadblock to harvesting blood stem cells for blood cancer transplants and identified a way to potentially circumvent the problem.
Five Mater Researchers have secured more than $12.5 million dollars in in the latest round of National Health and Medical Research Council (NHMRC) funding for their world-leading projects to...
Rosie Stoke has won The University of Queensland’s 2021 Three Minute Thesis (3MT) Competition and will go on to the Asia-Pacific 3MT Competition next month.
It is estimated over 110 000 people are living with blood cancer or a related blood disorder in Australia today and sadly 15 people lose their life to blood cancer each day.
Mater Researchers are calling on people with intellectual disabilities and autism as well as their carers to participate in a program aimed at improving the way healthcare services are delivered.
Mater Researcher and clinician-scientist, Dr Joshua Tobin has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award.
The Mater Inflammatory Bowel Disease (IBD) Research Group recently held their inaugural symposium to share novel research findings, and discuss innovation and the future of the group.
New research aims to shed light on reducing the loss of speech and language in epilepsy patients who require brain surgery to manage the condition.
National Science Week runs from the 14 – 22 August in Australia and is an annual celebration of science, research, medicine and technology in this country.
Mater Research is calling for 50 adults in south-east Queensland to join the global clinical trial of a potential new protein-based COVID-19 vaccine, the latest vaccine trial being run at Mater...